HEADER ONCOPROTEIN/INHIBITOR 07-FEB-23 8G3C TITLE CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH N-[(2'-CYANO[1,1'- TITLE 2 BIPHENYL]-4-YL)METHYL]-3-HYDROXY-6-METHYL-4-OXO-4H-PYRAN-2- TITLE 3 CARBOXAMIDE (COMPOUND 1, WDR5-MYC PPI INHIBITOR) COMPND MOL_ID: 1; COMPND 2 MOLECULE: WD REPEAT-CONTAINING PROTEIN 5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BMP2-INDUCED 3-KB GENE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WDR5, BIG3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS WDR5, WBM, MYC, SMALL MOLECULE, ONCOPROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.ZHAO REVDAT 3 25-OCT-23 8G3C 1 REMARK REVDAT 2 05-JUL-23 8G3C 1 JRNL REVDAT 1 28-JUN-23 8G3C 0 JRNL AUTH J.DING,L.LIU,Y.L.CHIANG,M.ZHAO,H.LIU,F.YANG,L.SHEN,Y.LIN, JRNL AUTH 2 H.DENG,J.GAO,D.R.SAGE,L.WEST,L.A.LLAMAS,X.HAO,S.KAWATKAR, JRNL AUTH 3 E.LI,R.K.JAIN,J.A.TALLARICO,S.M.CANHAM,H.WANG JRNL TITL DISCOVERY AND STRUCTURE-BASED DESIGN OF INHIBITORS OF THE WD JRNL TITL 2 REPEAT-CONTAINING PROTEIN 5 (WDR5)-MYC INTERACTION. JRNL REF J.MED.CHEM. V. 66 8310 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37307526 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00787 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC V5.8.0218 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 29048 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1469 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2356 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 159 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.55000 REMARK 3 B22 (A**2) : 0.56000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.138 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.122 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.085 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.779 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8G3C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1000272155. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97919 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30595 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 12.80 REMARK 200 R MERGE (I) : 0.15700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.00300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 8F1G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 0.2 M POTASSIUM ACETATE, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.40750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.21450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.10150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.21450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.40750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.10150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 22 REMARK 465 ALA A 23 REMARK 465 THR A 24 REMARK 465 GLN A 25 REMARK 465 SER A 26 REMARK 465 LYS A 27 REMARK 465 PRO A 28 REMARK 465 THR A 29 REMARK 465 PRO A 30 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS A 120 O ASP A 235 1455 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 234 31.13 -83.16 REMARK 500 LYS A 259 -47.00 -136.19 REMARK 500 ASP A 324 -60.39 -121.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 659 DISTANCE = 6.07 ANGSTROMS DBREF 8G3C A 22 334 UNP P61964 WDR5_HUMAN 22 334 SEQRES 1 A 313 SER ALA THR GLN SER LYS PRO THR PRO VAL LYS PRO ASN SEQRES 2 A 313 TYR ALA LEU LYS PHE THR LEU ALA GLY HIS THR LYS ALA SEQRES 3 A 313 VAL SER SER VAL LYS PHE SER PRO ASN GLY GLU TRP LEU SEQRES 4 A 313 ALA SER SER SER ALA ASP LYS LEU ILE LYS ILE TRP GLY SEQRES 5 A 313 ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SER GLY HIS SEQRES 6 A 313 LYS LEU GLY ILE SER ASP VAL ALA TRP SER SER ASP SER SEQRES 7 A 313 ASN LEU LEU VAL SER ALA SER ASP ASP LYS THR LEU LYS SEQRES 8 A 313 ILE TRP ASP VAL SER SER GLY LYS CYS LEU LYS THR LEU SEQRES 9 A 313 LYS GLY HIS SER ASN TYR VAL PHE CYS CYS ASN PHE ASN SEQRES 10 A 313 PRO GLN SER ASN LEU ILE VAL SER GLY SER PHE ASP GLU SEQRES 11 A 313 SER VAL ARG ILE TRP ASP VAL LYS THR GLY LYS CYS LEU SEQRES 12 A 313 LYS THR LEU PRO ALA HIS SER ASP PRO VAL SER ALA VAL SEQRES 13 A 313 HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SER SER SER SEQRES 14 A 313 TYR ASP GLY LEU CYS ARG ILE TRP ASP THR ALA SER GLY SEQRES 15 A 313 GLN CYS LEU LYS THR LEU ILE ASP ASP ASP ASN PRO PRO SEQRES 16 A 313 VAL SER PHE VAL LYS PHE SER PRO ASN GLY LYS TYR ILE SEQRES 17 A 313 LEU ALA ALA THR LEU ASP ASN THR LEU LYS LEU TRP ASP SEQRES 18 A 313 TYR SER LYS GLY LYS CYS LEU LYS THR TYR THR GLY HIS SEQRES 19 A 313 LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN PHE SER VAL SEQRES 20 A 313 THR GLY GLY LYS TRP ILE VAL SER GLY SER GLU ASP ASN SEQRES 21 A 313 LEU VAL TYR ILE TRP ASN LEU GLN THR LYS GLU ILE VAL SEQRES 22 A 313 GLN LYS LEU GLN GLY HIS THR ASP VAL VAL ILE SER THR SEQRES 23 A 313 ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SER ALA ALA SEQRES 24 A 313 LEU GLU ASN ASP LYS THR ILE LYS LEU TRP LYS SER ASP SEQRES 25 A 313 CYS HET YJN A 401 27 HETNAM YJN N-[(2'-CYANO[1,1'-BIPHENYL]-4-YL)METHYL]-3-HYDROXY-6- HETNAM 2 YJN METHYL-4-OXO-4H-PYRAN-2-CARBOXAMIDE FORMUL 2 YJN C21 H16 N2 O4 FORMUL 3 HOH *159(H2 O) SHEET 1 AA1 4 ALA A 36 LEU A 41 0 SHEET 2 AA1 4 ILE A 327 LYS A 331 -1 O ILE A 327 N LEU A 41 SHEET 3 AA1 4 ILE A 315 ALA A 320 -1 N ILE A 316 O TRP A 330 SHEET 4 AA1 4 VAL A 304 CYS A 309 -1 N ALA A 308 O ALA A 317 SHEET 1 AA2 4 VAL A 48 PHE A 53 0 SHEET 2 AA2 4 TRP A 59 SER A 64 -1 O ALA A 61 N LYS A 52 SHEET 3 AA2 4 LEU A 68 GLY A 73 -1 O TRP A 72 N LEU A 60 SHEET 4 AA2 4 PHE A 79 SER A 84 -1 O GLU A 80 N ILE A 71 SHEET 1 AA3 4 ILE A 90 TRP A 95 0 SHEET 2 AA3 4 LEU A 101 SER A 106 -1 O ALA A 105 N SER A 91 SHEET 3 AA3 4 LEU A 111 ASP A 115 -1 O TRP A 114 N LEU A 102 SHEET 4 AA3 4 CYS A 121 LEU A 125 -1 O LEU A 125 N LEU A 111 SHEET 1 AA4 4 VAL A 132 PHE A 137 0 SHEET 2 AA4 4 LEU A 143 SER A 148 -1 O VAL A 145 N ASN A 136 SHEET 3 AA4 4 VAL A 153 ASP A 157 -1 O TRP A 156 N ILE A 144 SHEET 4 AA4 4 CYS A 163 LEU A 167 -1 O LEU A 167 N VAL A 153 SHEET 1 AA5 4 VAL A 174 PHE A 179 0 SHEET 2 AA5 4 LEU A 185 SER A 190 -1 O VAL A 187 N HIS A 178 SHEET 3 AA5 4 CYS A 195 ASP A 199 -1 O TRP A 198 N ILE A 186 SHEET 4 AA5 4 CYS A 205 LEU A 209 -1 O LYS A 207 N ILE A 197 SHEET 1 AA6 4 VAL A 217 PHE A 222 0 SHEET 2 AA6 4 TYR A 228 THR A 233 -1 O LEU A 230 N LYS A 221 SHEET 3 AA6 4 THR A 237 ASP A 242 -1 O TRP A 241 N ILE A 229 SHEET 4 AA6 4 LYS A 247 TYR A 252 -1 O LEU A 249 N LEU A 240 SHEET 1 AA7 4 ALA A 264 SER A 267 0 SHEET 2 AA7 4 TRP A 273 SER A 276 -1 O TRP A 273 N SER A 267 SHEET 3 AA7 4 VAL A 283 ASN A 287 -1 O TYR A 284 N SER A 276 SHEET 4 AA7 4 ILE A 293 LEU A 297 -1 O VAL A 294 N ILE A 285 CRYST1 48.815 56.203 118.429 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020486 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017793 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008444 0.00000